Yorktown Management & Research Company’s Pediatrix Medical MD Stock Holding History

Yorktown Management & Research Company’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-4,000	Closed	-$241K	–	398
2017 Q2	$241K	Hold	4,000	–	–	0.08%	245
2017 Q1	$278K	Hold	4,000	–	–	0.07%	197
2016 Q4	$267K	Buy	+4,000	New	+$260K	0.07%	200
2015 Q2	–	Sell	-3,000	Closed	-$218K	–	494
2015 Q1	$218K	Buy	+3,000	New	+$209K	0.04%	414
2014 Q2	–	Sell	-6,000	Closed	-$372K	–	497
2014 Q1	$372K	Hold	6,000	–	–	0.07%	138
2013 Q4	$320K	Hold	6,000	–	–	0.06%	163
2013 Q3	$301K	Hold	6,000	–	–	0.06%	164
2013 Q2	$275K	Buy	+6,000	New	+$269K	0.06%	167

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Yorktown Management & Research Company's MD Position: Q3 2017 in Review

Yorktown Management & Research Company sold out of Pediatrix Medical (MD) in Q3 2017, closing a stake of 4,000 shares — an estimated $241K sold.

Yorktown Management & Research Company first reported a position in MD in Q2 2013 and held it in 8 quarters. The position peaked at $372K in Q1 2014. 337 funds tracked by Wall St. Rank hold MD as of Q3 2017.

Yorktown Management & Research Company reported no remaining Pediatrix Medical position as of Q3 2017 after selling out during the quarter.
Yorktown Management & Research Company sold 4,000 Pediatrix Medical shares in Q3 2017, an estimated $241K.
Yorktown Management & Research Company first reported a position in Pediatrix Medical in Q2 2013 and held it in 8 quarters.
Yorktown Management & Research Company's Pediatrix Medical position peaked at $372K in Q1 2014.
337 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2017.

Based on Yorktown Management & Research Company's 13F filing for Q3 2017, filed 8 Nov 2017.